文献速递产科母胎医学

ASPRE试验:阿司匹林对妊娠期平均动脉压和子宫动脉搏动指数轨迹的影响

ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

ASPRE试验的纵向二次分析纳入1620例早产子痫前期高风险孕妇,798例随机接受阿司匹林150 mg/天、822例接受安慰剂,从孕11-14周至36周或分娩。阿司匹林组与安慰剂组平均动脉压轨迹无显著差异,但子宫动脉搏动指数轨迹下降更陡,尤其在孕20周前。

要点

  • 早产子痫前期高风险孕妇中,阿司匹林150 mg/天不影响平均动脉压轨迹。
  • 阿司匹林组子宫动脉搏动指数轨迹较安慰剂组显著下降更陡,差异主要来自孕20周前。
  • 平均动脉压MoM分析交互作用P=0.340,子宫动脉搏动指数MoM分析交互作用P=0.006。

核心结论

  • 在早产子痫前期高风险孕妇中,孕早期开始阿司匹林150 mg/天不影响平均动脉压,但与平均子宫动脉搏动指数显著下降相关,尤其在孕20周前。

研究设计与样本

  • ASPRE试验的纵向二次分析,纳入1620例经胎儿医学基金会算法在孕11+0至13+6周识别的早产子痫前期高风险孕妇,798例随机接受阿司匹林150 mg/天、822例接受安慰剂,从孕11-14周至36周或分娩(以先到者为准)。
  • 在基线及孕19-24、32-34和36周随访时测量平均动脉压和子宫动脉搏动指数。
  • 采用广义加性混合模型,含治疗与孕周交互项,分析阿司匹林对平均动脉压和子宫动脉搏动指数轨迹的影响。

主要发现

  • 阿司匹林组798例和安慰剂组822例中,分别有5951次平均动脉压测量和5942次子宫动脉搏动指数测量。
  • 平均动脉压原始值和MoM值的轨迹在两组间无显著差异(平均动脉压MoM分析:治疗与孕周交互作用P=0.340)。
  • 子宫动脉搏动指数原始值和MoM值的轨迹在阿司匹林组较安慰剂组显著下降更陡,差异主要来自孕20周前更明显的下降(子宫动脉搏动指数MoM分析:治疗与孕周交互作用P=0.006)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout pregnancy are unknown. We aimed to investigate the effects of aspirin on mean arterial pressure (MAP) and mean uterine artery pulsatility index (UtA-PI) using repeated measures from women at increased risk of preterm pre-eclampsia. METHODS: This was a longitudinal secondary analysis of the Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Pre-eclampsia Prevention (ASPRE) trial using repeated measures of MAP and UtA-PI. In the trial, 1620 women at increased risk of preterm pre-eclampsia were identified using the Fetal Medicine Foundation algorithm at 11 + 0 to 13 + 6 weeks, of whom 798 were randomly assigned to receive 150 mg/day aspirin and 822 were assigned to receive placebo daily from 11-14 weeks to 36 weeks of gestation or delivery, whichever came first. MAP and UtA-PI were measured at baseline and follow-up visits at 19-24, 32-34 and 36 weeks of gestation. Generalized additive mixed models with treatment by gestational age interaction terms were used to investigate the effects of aspirin on MAP and UtA-PI trajectories over time. RESULTS: Among 798 participants in the aspirin group and 822 in the placebo group, there were 5951 MAP and 5942 UtA-PI measurements. Trajectories of raw and multiples of the median (MoM) values of MAP did not differ significantly between the two groups (MAP MoM analysis: P-value for treatment by gestational age interaction, 0.340). In contrast, trajectories of raw and MoM values of UtA-PI showed a significantly steeper decline in the aspirin group than in the placebo group, with the difference mainly driven by a more pronounced reduction before 20 weeks of gestation (UtA-PI MoM analysis: P-value for treatment by gestational age interaction, 0.006). CONCLUSIONS: In women at increased risk of preterm pre-eclampsia, 150 mg/day aspirin initiated in the first trimester does not affect MAP but is associated with a significant decrease in mean UtA-PI, particularly before 20 weeks of gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rolnik DL, Syngelaki A, O'Gorman N, et al. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet Gynecol. 2023. PMID: 37058400. doi:10.1002/uog.26222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。